Order results by:
| Issue | Title | |
| Vol 12, No 4 (2016) | Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk | Abstract similar documents |
| O. M. Drapkina, O. N. Korneeva | ||
| "... The problem of non-alcoholic fatty liver disease (NAFLD), which is an independent risk factor ..." | ||
| Vol 13, No 5 (2017) | NON-ALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK: SCIENTIFIC PROBLEM STATE | Abstract similar documents |
| O. M. Drapkina, A. A. Yafarova | ||
| "... Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide, which ..." | ||
| Vol 17, No 6 (2021) | Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy | Abstract similar documents |
| A. V. Nelidova, M. A. Livzan, N. A. Nikolaev, T. S. Krolevets | ||
| "... The association of non-alcoholic fatty liver disease (NAFLD) and cardiovascular risk is currently ..." | ||
| Vol 13, No 1 (2017) | SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION | Abstract similar documents |
| S. N. Bel'diev | ||
| "... and nonalcoholic fatty liver disease (NAFLD) or other hepatobiliary diseases, especially in cases when elevated ..." | ||
| Vol 5, No 6 (2009) | STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY? | Abstract similar documents |
| I. N. Grigorieva, Y. M. Pozdnyakov | ||
| "... Results of combined therapy of gallstone disease (GSD), non-alcoholic fatty liver disease (NAFLD ..." | ||
| Vol 9, No 2 (2013) | STATIN SAFETY REVISITED DATA | Abstract similar documents |
| O. M. Drapkina | ||
| "... fatty liver disease, viral hepatitis C are considered separately. ..." | ||
| Vol 7, No 5 (2011) | DIETARY FATTY ACIDS. EFFECTS ON THE RISK OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| N. V. Perova, V. A. Metel'skaya, E. I. Sokolov, G. N. Shchukina, V. M. Fomina | ||
| "... The world publications data about the impact of consumption and the fatty acids ratio in consumed ..." | ||
| Vol 11, No 3 (2015) | OMEGA-3 FATTY ACIDS AND AGE-RELATED DISEASES: REALITIES AND PROSPECTS | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel' | ||
| "... Efficacy of omega-3 fatty acids in cardiology is so high that in many countries omega-3 fatty ..." | ||
| Vol 15, No 3 (2019) | Disorders of the Cardiovascular System in Patients with Chronic Viral Hepatitis | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko | ||
| Vol 8, No 1 (2012) | OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES | Abstract similar documents |
| A. V. Govorin, A. P. Filev | ||
| "... For today there are convincing evidences of beneficial effect of ω-3 polyunsaturated fatty acids ..." | ||
| Vol 18, No 2 (2022) | Antiarrhythmic and Hemodynamic Effects of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Diseases | Abstract similar documents |
| A. N. Zakirova, N. E. Zakirova | ||
| "... and clinical studies indicating the use of ω-3 PUFA (polyunsaturated fatty acids) contributes to reduce ..." | ||
| Vol 11, No 5 (2015) | The role of peptide hormones (adiponectin, leptin, insulin) in the pathogenesis of atherosclerosis | Abstract similar documents |
| S. A. Smetnev, A. N. Meshkov | ||
| "... Currently, cardiovascular diseases (CVD) remain the main problem in the world and in Russia ..." | ||
| Vol 19, No 3 (2023) | Nutraceutical support in the prevention and treatment of cardiovascular diseases | Abstract similar documents |
| E. V. Gracheva, E. A. Starovoytova, E. S. Kulikov, N. A. Kirillova, S. V. Fedosenko, M. A. Balaganskaya, D. V. Kromka | ||
| "... Cardiovascular disease is the most common cause of death worldwide. In this regard ..." | ||
| Vol 15, No 2 (2019) | Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology, the Russian Scientific Medical Society of Therapists, the Eurasian Association of Therapists, the Russian National Atherosclerosis Society, the Russian Association of Endocrinologists, and the National League of Cardiologic Genetics | Abstract similar documents |
| G. P. Arutyunov, S. A. Boytsov, M. I. Voyevoda, V. S. Gurevich, O. M. Drapkina, V. V. Kukharchuk, A. I. Martynov, I. V. Sergiyenko, M. V. Shestakova, A. S. Aliyeva, N. M. Akhmedzhanov, M. G. Bubnova, А. S. Galyavich, I. G. Gordeyev, M. V. Ezhov, Yu. A. Karpov, V. O. Konstantinov, S. V. Nedogoda, E. M. Nifontov, Ya. A. Orlova, A. V. Panov, S. A. Sayganov, V. V. Skibitskiy, E. I. Tarlovskaya, S. A. Urazgildeyeva, Yu. Sh. Khalimov | ||
| "... high and extremely high cardiovascular risk. The indication for the pharmacological treatment to reduce ..." | ||
| Vol 16, No 2 (2020) | Gut Microbiota Composition and Metabolites as the new Determinants of Cardiovascular Pathology Development | Abstract similar documents |
| O. M. Drapkina, A. N. Kaburova | ||
| "... . In this group cardiovascular diseases (CVD) are known to be the leading cause of death which pathogenesis still ..." | ||
| Vol 11, No 2 (2015) | THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT? | Abstract similar documents |
| S. Yu. Martsevich, O. V. Lerman, N. P. Kutishenko, A. Yu. Suvorov | ||
| "... with cardiovascular diseases and concomitant chronic liver diseases. Material and methods. Сross-sectional ..." | ||
| Vol 17, No 5 (2021) | Impact of Gut Microbiota on the Risk of Cardiometabolic Diseases Development | Abstract similar documents |
| L. E. Vasilyeva, O. M. Drapkina | ||
| "... for cardiovascular diseases, in particular obesity, is an actual task. The purpose of this review is analyzing ..." | ||
| Vol 20, No 2 (2024) | Comparative placebo-controlled study on the effect of dietary supplements containing omega-3 polyunsaturated fatty acids on hemodynamics and lipid metabolism in postmenopausal women | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova, A. A. Kudrjavtseva, A. I. Skripka, A. V. Zhilenko, E. V. Kolpachkova, D. K. Varvarina | ||
| "... Aim. To study the effect of dietary supplements containing omega-3 polyunsaturated fatty acids ..." | ||
| Vol 11, No 2 (2015) | ALCOHOL-INDUCED CARDIAC RHYTHM DISORDERS IN PATIENTS WITH ALCOHOL DEPENDENCE: TYPES OF ARRHYTHMIAS, MECHANISMS OF ORIGIN, PARTICULARITIES OF COURSE AND ANTIARRHYTHMIC THERAPY | Abstract similar documents |
| A. S. Aksel'rod, A. L. Syrkin | ||
| "... with alcoholic disease with any cardiovascular disease; group 2 (n=70) - patients with alcoholic disease without ..." | ||
| Vol 11, No 6 (2015) | Alcohol consumption in patients with cardiovascular diseases (results of the survey of cardiac patients in outpatient practice) | Abstract similar documents |
| O. D. Ostroumova, I. E. Nikolaeva, S. Ya. Eregin, I. V. Pokrovskaya, K. A. Ishchenko | ||
| "... Aim. To study the frequency and characteristics of alcohol use in outpatients with cardiovascular ..." | ||
| Vol 12, No 3 (2016) | THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA? | Abstract PDF (Eng) similar documents |
| S. N. Bel'diev | ||
| "... to use statins in patients with cardiovascular diseases and concomitant chronic liver diseases. Analysis ..." | ||
| Vol 10, No 2 (2014) | STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov | ||
| "... Aim. To assess the potential of ursodeoxycholic acid (UDCA) in the prevention of liver dysfunction ..." | ||
| Vol 11, No 3 (2015) | THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov | ||
| "... with statins and UDCA is effective and safe in patients with high cardiovascular risk and concomitant liver ..." | ||
| Vol 19, No 1 (2023) | Analysis of The Use of PCSK9 Inhibitors in Clinical Practice | Abstract similar documents |
| S. Yu. Volkova, L. A. Boyarskaya, P. Yu. Toropygin, I. A. Morozov, E. A. Boyarskaya | ||
| "... high cardiovascular risk, аccording to long observations in real clinical practice. Material ..." | ||
| Vol 14, No 4 (2018) | Role of Gut Microbiota in the Pathogenesis of Cardiovascular Diseases and Metabolic Syndrome | Abstract similar documents |
| O. M. Drapkina, O. E. Shirobokikh | ||
| "... The role of gut microbiota in the pathogenesis of cardiovascular diseases (CVD) and metabolic ..." | ||
| Vol 2, No 3 (2006) | NEW EVIDENCES OF POSSIBILITY OF OMEGA-3 ACIDS USE FOR MYOCARDIAL INFARCTION SECONDARY PREVENTION | Abstract similar documents |
| A. I. Martinov, V. L. Chomenko | ||
| "... fatty acids (PUFAs) were analyzed. It was proved that PUFAs class omega-3 have positive effects ..." | ||
| Vol 3, No 3 (2007) | STRESS: WHAT WE ACTUALLY KNOW ABOUT THIS RISK FACTOR? | Abstract similar documents |
| R. G. Oganov, G. V. Pogosova | ||
| "... Results of current studies devoted to relationship between stress and cardiovascular morbidity ..." | ||
| Vol 10, No 6 (2014) | ALCOHOLIC CARDIOMYOPATHY: BASIC ASPECTS OF EPIDEMIOLOGY, PATHOGENESIS AND PHARMACOTHERAPY | Abstract similar documents |
| A. O. Yusupova | ||
| "... Data on the epidemiology and pathogenesis of alcoholic cardiomyopathy (ACMP) are presented ..." | ||
| Vol 6, No 4 (2010) | HYPOANDROGEN CONDITION AND CARDIOVASCULAR DISEASES: ACTUAL QUESTIONS OF COMORBIDITY IN CLINICAL PRACTICE | Abstract similar documents |
| G. G. Sharvadze, D. G. Kurbatov, E. A. Poddubskaya, M. N. Mamedov | ||
| "... The correlation of age-dependent reduction in sex hormones level and changes of cardiovascular ..." | ||
| Vol 9, No 1 (2013) | EFFECT OF DIFFERENT GLUCOSE BLOOD LEVELS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES AND COMPLICATIONS | Abstract similar documents |
| E. V. Akhmedova, Z. A. Toguzova, M. N. Mamedov | ||
| "... growth rate of mortality. Glucose blood levels should be monitored to reduce the risk of cardiovascular ..." | ||
| Vol 4, No 1 (2008) | ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko | ||
| Vol 4, No 1 (2008) | WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL | Abstract similar documents |
| M. N. Mamedov, M. B. Stroeva | ||
| "... Primary prevention of diabetes in persons with high cardiovascular risk is an actual problem ..." | ||
| Vol 1, No 1 (2005) | MENOPAUSE AND CARDIOVASCULAR RISK | Abstract similar documents |
| D. A. Anichkov, N. A. Shostak, A. D. Zhuravleva | ||
| "... A role of menopause as a cardiovascular risk factor is reviewed. Menopause influence ..." | ||
| Vol 18, No 1 (2022) | Cardiovascular Effects of Metformin | Abstract similar documents |
| B. T. Kurmanbekova, A. M. Noruizbaeva | ||
| "... , progression and mortality from cardiovascular diseases (CVD). The world communities are faced ..." | ||
| Vol 20, No 5 (2024) | Lipoprotein(a), atherosclerosis and cardiovascular risk | Abstract similar documents |
| E. A. Polyakova, Iu. S. Khalimov, E. A. Bazhenova, T. M. Bakher | ||
| "... cardiovascular diseases. The atherogenicity of Lp(a) is 6 times higher than that of low-density lipoproteins ..." | ||
| Vol 10, No 1 (2014) | MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) | Abstract PDF (Eng) similar documents |
| A. M. Kalinina | ||
| "... Aim. To evaluate in a prospective 10-year follow-up study cardiovascular mortality rate ..." | ||
| Vol 8, No 2 (2012) | CLINICAL IMPLICATION OF FATTY ACID CHANGES IN PATIENTS WITH PRIMARY GOUT ASSOCIATED WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| N. N. Kushnarenko, A. V. Govorin | ||
| "... Aim. To study blood levels of non-esterified fatty acids (NEFAs) and adenyl nucleotides, and fatty ..." | ||
| Vol 9, No 1 (2013) | THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS | Abstract similar documents |
| A. O. Malygin, V. L. Doshchitsin | ||
| "... Antiarrhythmic effect of omega-3 polyunsaturated fatty acids (ω-3 PUFA), eicosapentaenoic ..." | ||
| Vol 16, No 3 (2020) | The Value of Omega-3 Fatty Acids in the Prevention of Heart Rhythm Disorders | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... One of the trends in modern cardiology is the use of omega-3 polyunsaturated fatty acids (ω-3 PUFA ..." | ||
| Vol 13, No 3 (2017) | ROLE OF PULMONARY HYPERTENSION IN THE DEVELOPMENT OF CIRRHOTIC CARDIOMYOPATHY | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, E. V. Radaeva | ||
| "... Aim. To investigate the presence of pulmonary hypertension (PH) in patients with viral liver ..." | ||
| Vol 15, No 2 (2019) | Remodeling of the Pulmonary Circulation in Patients with Viral Liver Cirrhosis | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko | ||
| "... of antiviral therapy on these parameters in patients with viral liver cirrhosis (VLC). Material and methods ..." | ||
| Vol 16, No 4 (2020) | Epicardial Adipose Tissue as a New Target of Therapeutic Interventions | Abstract similar documents |
| M. A. Druzhilov, T. Y. Kuznetsova | ||
| "... be considered as a potentially modifiable factor of cardiovascular risk, the various therapeutic interventions ..." | ||
| Vol 16, No 4 (2020) | Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues | Abstract similar documents |
| M. V. Zhuravleva, A. B. Prokofiev, E. V. Shikh, S. Yu. Serebrova, G. I. Gorodetskaya, E. Yu. Demchenkova | ||
| "... in a significant proportion of patients with atherosclerotic cardiovascular diseases (ACVD) is impossible ..." | ||
| Vol 5, No 3 (2009) | RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. V. Minakov, R. A. Khokhlov, T. N. Kuznetsova, Y. V. Popovskaya, D. V. Snustikov, E. E. Tsareva, V. I. Yarliykova, N. M. Akhmedzhanov | ||
| "... to provide high level of compliance in patients with cardiovascular diseases. ..." | ||
| Vol 5, No 4 (2009) | PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko | ||
| "... The definition of primary prevention of cardiovascular diseases is presented. Statins preventive ..." | ||
| Vol 5, No 6 (2009) | EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY) | Abstract similar documents |
| I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, M. I. Shupina, A. V. Rudakov, T. S. Bondarenko | ||
| "... with different cardiovascular risk (according to arterial hypertension (HT) risk stratification) in real clinical ..." | ||
| Vol 6, No 1 (2010) | THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| "... Data of the evidence based medicine about bisoprolol treatment of patients with cardiovascular ..." | ||
| Vol 6, No 5 (2010) | LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS? | Abstract similar documents |
| I. V. Zhirov | ||
| "... with cardiovascular diseases are presented. The main practical ways to reduce the possible gastrointestinal ..." | ||
| Vol 7, No 6 (2011) | DETERMINANTS OF PREVENTIVE BEHAVIOR REGARDING CARDIOVASCULAR DISEASES AND RISK FACTORS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND CHRONIC ISCHEMIC HEART DISEASE | Abstract similar documents |
| D. Yu. Platonov, T. A. Kostjuk, A. I. Brandt, O. V. Tsygankova | ||
| "... logistic regression. Results. Awareness of the cardiovascular diseases (CVD) and its prevention (odds ratio ..." | ||
| Vol 9, No 3 (2013) | STATINS AND RISK OF INFECTIOUS DISEASES | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel' | ||
| Vol 9, No 4 (2013) | STATINS IN PREVENTION OF ISCHEMIC STROKE | Abstract similar documents |
| A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk | ||
| Vol 9, No 4 (2013) | NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY | Abstract similar documents |
| A. V. Rudenko, B. A. Rudenko | ||
| "... cardiovascular events incidence in patients with atherosclerosis, even if they have no arterial hypertension ..." | ||
| Vol 10, No 5 (2014) | STATINS USE IN THE PERIOPERATIVE PERIOD ACCORDING TO THE EVIDENCE-BASED MEDICINE | Abstract similar documents |
| V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev | ||
| "... modification of cardiovascular complications in the perioperative period. Particular attention has recently ..." | ||
| Vol 1, No 3 (2005) | RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS | Abstract similar documents |
| D. A. Anichkov, N. A. Shostak | ||
| "... The cardiovascular risk factors in patients with rheumatoid arthritis (RA) are reviewed ..." | ||
| Vol 5, No 1 (2009) | SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, A. A. Serazhim, T. V. Bobkova, L. P. Volkonskaya, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, J. V. Lukina, M. A. Maksimova, A. A. Serazhim, S. N. Tolpygina, E. V. Shilova | ||
| "... – arterial hypertension (HT) and hypercholesterolemia (HH) in patients with high risk of cardiovascular ..." | ||
| Vol 4, No 4 (2008) | BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST | Abstract similar documents |
| L. N. Malaj | ||
| "... Usage of β-blockers (BB) for treatment of patients with cardiovascular diseases is discussed ..." | ||
| Vol 17, No 4 (2021) | Obstructive sleep apnea and cardiovascular comorbidity: common pathophysiological mechanisms to cardiovascular disease | Abstract similar documents |
| M. V. Agaltsov, O. M. Drapkina | ||
| "... Obstructive sleep apnea (OSA) is associated with many cardiovascular and metabolic diseases. Sleep ..." | ||
| Vol 12, No 1 (2016) | Effect of magnesium on the cardiovascular system in women | Abstract PDF (Eng) similar documents |
| E. A. Ulubieva, A. G. Avtandilov | ||
| "... Recent scientific data on the influence of magnesium on the cardiovascular and reproductive system ..." | ||
| Vol 6, No 4 (2010) | EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK | Abstract similar documents |
| N. V. Perova, E. I. Sokolov, G. N. Shchukina, V. A. Metelskaya | ||
| Vol 8, No 3 (2012) | MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES | Abstract similar documents |
| A. V. Govorin, A. P. Filev | ||
| "... in different cardiovascular diseases are obtained. Physiological significance of magnesium is determined by its ..." | ||
| Vol 17, No 1 (2021) | Basic Aspects of Seasonal Cardiovascular Mortality | Abstract similar documents |
| G. F. Andreeva, V. M. Gorbunov | ||
| "... The review demonstrates the main aspects of seasonal cardiovascular mortality. Climatic factors ..." | ||
| Vol 14, No 2 (2018) | DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT | Abstract similar documents |
| N. В. Perepech, A. V. Tregubov | ||
| "... for primary and secondary prevention of cardiovascular diseases. 276 questionnaires filled out by 185 ..." | ||
| Vol 9, No 6 (2013) | COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY | Abstract similar documents |
| I. V. Zhirov, G. K. Sarbalinova, S. N. Tereschenko | ||
| "... included into the open randomized study. Idiopathic DCMP (IDCMP) was diagnosed in 26 patients and alcoholic ..." | ||
| Vol 14, No 3 (2018) | FEATURES OF HEART LESIONS IN PATIENTS WITH VIRAL LIVER CIRRHOSIS | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin | ||
| "... of antiviral therapy on certain cardiohemodynamic parameters in patients with viral liver cirrhosis (VLC ..." | ||
| Vol 12, No 6 (2016) | EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, E. V. Radaeva | ||
| "... in patients with chronic viral hepatitis (CVH) and viral liver cirrhosis (VLC). Material and methods. Doppler ..." | ||
| Vol 14, No 4 (2018) | Some Morpho-Functional Changes of the Left Heart in Patients with Viral Liver Cirrhosis | Abstract similar documents |
| M V. Chistyakova, A. V. Govorin, N. N. Kushnarenko | ||
| Vol 4, No 4 (2008) | CHOICE OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND CHRONIC LIVER DISEASES | Abstract similar documents |
| M. N. Mamedov, O. M. Drapkina | ||
| "... A number of comorbid patients is increasing significantly. Chronic diffusive liver diseases meet ..." | ||
| Vol 20, No 5 (2024) | Impact of non-high-density lipoprotein cholesterol in mortality and cardiovascular events among middle-aged Russian men: 40 years ago and now | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, A. E Imaeva, Yu. A Balanova, V. A Kutsenko, A. V Kapustina, V. A Metelskaya, N. A Imaeva, B. M Nazarov, O. E Ivlev, E. B Yarovaya, O. M Drapkina | ||
| "... in relation to cardiovascular events, all-cause and cause-specific mortality and among middle-aged Russian men ..." | ||
| Vol 17, No 4 (2021) | Inflammation and Comorbidity. Are There any Chances to Improve the Prognosis in Patients with Extremely High Cardiovascular Risk? | Abstract similar documents |
| M. V. Zykov, O. L. Barbarash | ||
| "... in a special category of patients with extremely high cardiovascular risk, as well as in patients with recent ..." | ||
| Vol 18, No 5 (2022) | Assessment and Correction of the Cardiac Complications Risk in Non-cardiac Operations – What's New? | Abstract similar documents |
| A. N. Sumin | ||
| "... Cardiovascular complications after non-cardiac surgery are the leading cause of 30-day mortality ..." | ||
| Vol 19, No 2 (2023) | Antithrombotic Therapy in Patients with Paroxysmal Atrial Fibrillation after Catheter Treatment | Abstract similar documents |
| O. R. Eshmatov, M. S. Khlynin, R. E. Batalov, E. A. Archakov, I. V. Kisteneva | ||
| Vol 19, No 1 (2023) | Microbiota and Cardiovascular Diseases: Mechanisms of Influence and Correction Possibilities | Abstract similar documents |
| A. V. Gorbenko, Y. P. Skirdenko, K. A. Andreev, M. M. Fedorin, N. A. Nikolaev, M. A. Livzan | ||
| "... types. The link between the gut microbiota and cardiovascular disease (CVD) is being actively ..." | ||
| Vol 12, No 3 (2016) | REPORT ON THE ROUND-TABLE MEETING: "REGISTERS IN CARDIOLOGY: THE BASIC RULES OF MANAGEMENT, MODERN EXPERIENCE AND THE RESULTS OF THEIR CREATION IN THE VARIOUS REGIONS OF THE RUSSIAN FEDERATION" | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, M. M. Loukianov, N. P. Kutishenko | ||
| "... of various cardiovascular diseases (CVD) were among participants of the meeting. The importance of modern ..." | ||
| Vol 12, No 4 (2016) | Comparative Analysis of All-cause and Cardiovascular Mortality in Moscow and Irkutsk | Abstract PDF (Eng) similar documents |
| F. I. Belyalov, I. V. Samorodskaya, S. V. Pogodaeva | ||
| "... Aim. To study standardized all-cause mortality and cardiovascular mortality (or deaths due ..." | ||
| Vol 12, No 5 (2016) | The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies | Abstract similar documents |
| E. K. Butina, E. V. Bochkareva | ||
| "... Measures for the prevention of cardiovascular diseases (CVD) are more effective ..." | ||
| Vol 5, No 2 (2009) | DOCTOR INERTNESS AS A FACTOR DISTURBING EFFECTIVE TREATMENT OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. V. Minakov, R. A. Khokhlov, G. I. Furmenko, N. M. Akhmedzhanov | ||
| "... which treat and follow-up patients with cardiovascular diseases (CVD). Material and methods ..." | ||
| Vol 8, No 6 (2012) | THE RELATIONSHIP OF CARDIOVASCULAR RISK FACTORS AND ARTERIAL WALL STIFFNESS IN WOMEN WITH A HIGH ACTIVITY OF RHEUMATOID ARTHRITIS | Abstract similar documents |
| D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov | ||
| "... pulse wave) with cardiovascular risk factors in women with rheumatoid arthritis (RA). Material ..." | ||
| Vol 5, No 3 (2009) | CLINICAL AND ECONOMICAL RATIONALES OF CARDIOVASCULAR RISK EVALUATION AT WORKPLACE | Abstract similar documents |
| A. V. Kontsevaya, A. M. Kalinina, Yu. M. Pozdnyakov, S. V. Belonosova, M. B. Khudyakov | ||
| "... Aim. To study clinical and economical rationales for cardiovascular risk evaluation at workplace ..." | ||
| Vol 5, No 3 (2009) | ARTERIAL HYPERTENSION IN PATIENTS WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
| N. M. Nikitina, A. P. Rebrov | ||
| Vol 5, No 4 (2009) | COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS | Abstract PDF (Eng) similar documents |
| N. A. Karoli, A. P. Rebrov | ||
| "... Aim. To study prevalence and features of cardiovascular diseases (arterial hypertension, ischemic ..." | ||
| Vol 13, No 1 (2017) | THE LINK BETWEEN VITAMIN В12 DEFICIENCY, RISK OF CARDIOVASCULAR DISEASES AND AGING PROCESS | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel | ||
| "... of the cardiovascular system. Its connections to the increased incidence of myocardial infarction, stroke ..." | ||
| Vol 13, No 3 (2017) | ARTERIAL STIFFNESS AND CARDIOVASCULAR RISK FACTORS IN YOUNG MEN (41-44 YEARS) | Abstract PDF (Eng) similar documents |
| O. Yu. Isaykina, V. B. Rozanov, E. Yu. Zvolinskaya, H. S. Pugoeva, A. A. Alexandrov | ||
| "... Aim. To study the relationship of individual cardiovascular risk factors with arterial stiffness ..." | ||
| Vol 13, No 6 (2017) | SMOKING AS A RISK FACTOR OF CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 1. Smoking Prevalence and Impact on Prognosis | Abstract similar documents |
| O. D. Ostroumova, A. A. Izvekov, N. Yu. Voevodina | ||
| "... of acute cardiovascular events during smoking include the activation of inflammation, platelet aggregation ..." | ||
| Vol 14, No 1 (2018) | SMOKING AS A RISK FACTOR FOR CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 2. Advantages of quitting smoking. Strategies to quit smoking | Abstract similar documents |
| O. D. Ostroumova, I. I. Kopchjonov, T. F. Guseva | ||
| "... reduces the risk of developing stable and unstable angina, acute myocardial infarction, cardiovascular ..." | ||
| Vol 7, No 4 (2011) | METHODS OF ASSISTANCE FOR SMOKING CESSATION IN INTERNATIONAL CLINICAL RECOMMENDATIONS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE | Abstract similar documents |
| M. S. Berezhnova | ||
| "... of cardiovascular disease. There are a lot of approaches to drop smoking including innovative pharmacotherapy ..." | ||
| Vol 6, No 6 (2010) | THE CHOICE OF DRUG FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE: CASE STUDY OF BETA-BLOCKERS | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina | ||
| "... concerning the evidence base for effects of various beta-blockers on the outcomes of cardiovascular diseases ..." | ||
| Vol 6, No 5 (2010) | EFFECT OF BETA-BLOCKERS ON BLOOD PRESSURE, PERIOPERATIVE COMPLICATIONS AND HOSPITAL STAY DURATION IN PATIENTS WITH INTERMEDIATE RISK OF CARDIOVASCULAR COMPLICATIONS AFTER ROUTINE CHOLECYSTECTOMY: AN OPEN COMPARATIVE RANDOMIZED STUDY | Abstract similar documents |
| O. L. Barbarash, R. V. Repnikova, T. V. Shoforus, O. I. Golofaeva | ||
| "... year worldwide, and cardiovascular complications happen in 500 000 - 900 000 patients. Aim ..." | ||
| Vol 6, No 5 (2010) | PHOSPHODIESTERASE-5 INHIBITORS USE IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE | Abstract similar documents |
| M. N. Mamedov, G. G. Sharvadze, E. A. Poddubsky, A. K. Ausheva | ||
| "... of ED in the majority of men (about 80% of patients) is cardiovascular diseases (atherosclerosis ..." | ||
| Vol 11, No 1 (2015) | VASCULAR COMORBIDITY: GENERAL APPROACHES TO PREVENTION AND TREATMENT | Abstract PDF (Eng) similar documents |
| R. G. Oganov | ||
| "... The problem of vascular comorbidity in patients with cardiovascular diseases, its effect ..." | ||
| Vol 9, No 1 (2013) | CLINICAL AND COST EFFECTIVENESS OF PREVENTIVE COUNSELING OF YOUNG PATIENTS WITH ARTERIAL HYPERTENSION IN PRIMARY HEALTH CARE | Abstract similar documents |
| M. I. Shupina, O. Ju. Korennova, E. N. Loginova | ||
| "... . The total cardiovascular risk in patients of “Health school” and "Typical practice" groups after 12 months ..." | ||
| Vol 9, No 4 (2013) | USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES? | Abstract similar documents |
| V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev | ||
| "... of risk modification of cardiovascular complications in the perioperative period. Therefore, special ..." | ||
| Vol 11, No 2 (2015) | LOW SODIUM DIET: PROS AND CONS | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel' | ||
| Vol 10, No 1 (2014) | ARTERIAL STIFFNESS AND CHRONIC KIDNEY DISEASE: CAUSES AND CONSEQUENCES | Abstract similar documents |
| J. D. Kobalava, Yu. V. Kotovskaya, S. V. Villevalde, A. E. Soloveva, I. M. Amirbegishvili | ||
| "... Chronic kidney disease (CKD) is associated with increased cardiovascular risk. CKD ..." | ||
| Vol 10, No 1 (2014) | MAGNESIUM DEFICIENCY AND CARDIOVASCULAR DISEASES: TIME TO ACT | Abstract similar documents |
| E. I. Trisvetova | ||
| "... Progression of cardiovascular disease is often caused by a deficiency of magnesium in the human ..." | ||
| Vol 10, No 4 (2014) | MODERN PRINCIPLES OF QUALITY ASSESSMENT OF CARDIOVASCULAR DISEASES TREATMENT | Abstract similar documents |
| A. Yu. Suvorov, S. Yu. Martsevich | ||
| "... The most common ways of assessment of cardiovascular diseases treatment abroad, approaches ..." | ||
| Vol 16, No 4 (2020) | Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice | Abstract similar documents |
| D. V. Nebieridze, N. M. Akhmedzhanov, S. A. Davitashvili, A. S. Lishuta, A. S. Safaryan | ||
| "... to cardiovascular risk require an optimization of their pharmacotherapy in clinical practice. Aim. To study ..." | ||
| Vol 11, No 5 (2015) | Perioperative assessment of troponin level in the non-cardiac interventions: is there such a need? | Abstract similar documents |
| A. N. Sumin | ||
| Vol 1, No 1 (2005) | ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES | Abstract similar documents |
| Y. A. Karpov | ||
| "... risk due to cardiovascular reasons. Favorable therapeutic effects of inhibiting RAS activity ..." | ||
| Vol 8, No 4 (2012) | UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina | ||
| "... cardiovascular diseases is one of the priorities of modern medicine. This therapy usually consists of several ..." | ||
| Vol 8, No 5 (2012) | ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE? | Abstract similar documents |
| S. A. Boldueva, I. A. Leonova | ||
| "... and the main indications are discussed. ASA use for primary cardiovascular diseases prevention and its possible ..." | ||
| 1 - 100 of 712 Items | 1 2 3 4 5 6 7 8 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
